Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Journal of the International AIDS Society
|
December 9, 2024
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort
Brenda Gati Mirembe, Deborah Donnell, Meighan Krows, et al.
BMJ Open
|
May 1, 2024
Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT)
Stephanie Ramboarina, Tania Crucitti, Katherine Gill, et al.
The New England Journal of Medicine
|
July 24, 2024
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Linda-Gail Bekker, Moupali Das, Quarraisha Abdool Karim, et al.
Frontiers in Immunology
|
October 2, 2025
No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCT
Sinead Delany-Moretlwe, Hakim-Moulay Dehbi, Izukanji Sikazwe, et al.
PLOS Global Public Health
|
December 5, 2024
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 4, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Catherine Riou, Jinal N Bhiman, Yashica Ganga, et al.
PLOS Global Public Health
|
April 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Catherine Riou, Jinal N Bhiman, Yashica Ganga, et al.
Nature Communications
|
October 6, 2025
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Journal of the International AIDS Society
|
December 9, 2024
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort
Brenda Gati Mirembe, Deborah Donnell, Meighan Krows, et al.
BMJ Open
|
May 1, 2024
Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT)
Stephanie Ramboarina, Tania Crucitti, Katherine Gill, et al.
The New England Journal of Medicine
|
July 24, 2024
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Linda-Gail Bekker, Moupali Das, Quarraisha Abdool Karim, et al.
Frontiers in Immunology
|
October 2, 2025
No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCT
Sinead Delany-Moretlwe, Hakim-Moulay Dehbi, Izukanji Sikazwe, et al.
PLOS Global Public Health
|
December 5, 2024
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 4, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Catherine Riou, Jinal N Bhiman, Yashica Ganga, et al.
PLOS Global Public Health
|
April 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Catherine Riou, Jinal N Bhiman, Yashica Ganga, et al.
Nature Communications
|
October 6, 2025
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett, et al.
Page
of 8